Articles with "recurrent brca1" as a keyword



Photo from wikipedia

Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Investigational New Drugs"

DOI: 10.1007/s10637-020-00965-8

Abstract: Background Previous studies on neoadjuvant therapy for BRCA1-driven ovarian cancer (OC) demonstrated higher efficacy of mitomycin C plus cisplatin combination as compared to standard drug schemes. These data call for evaluation of the utility of… read more here.

Keywords: mitomycin plus; treatment; recurrent brca1; ovarian cancer ... See more keywords